T. Rowe Price Associates’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
66,367
+39,004
| +143% | +$1.9M | ﹤0.01% | 1443 |
|
|
2025
Q1 | $932K | Buy |
27,363
+2,800
| +11% | +$95.4K | ﹤0.01% | 1992 |
|
|
2024
Q4 | $967K | Buy |
24,563
+800
| +3% | +$31.5K | ﹤0.01% | 1975 |
|
|
2024
Q3 | $1.12M | Sell |
23,763
-396,932
| -94% | -$18.7M | ﹤0.01% | 1931 |
|
|
2024
Q2 | $22.7M | Sell |
420,695
-179,539
| -30% | -$9.7M | ﹤0.01% | 928 |
|
|
2024
Q1 | $40.9M | Sell |
600,234
-264,112
| -31% | -$18M | 0.01% | 776 |
|
|
2023
Q4 | $54.1M | Sell |
864,346
-5,291
| -0.6% | -$331K | 0.01% | 687 |
|
|
2023
Q3 | $39.5M | Sell |
869,637
-12,738
| -1% | -$578K | 0.01% | 752 |
|
|
2023
Q2 | $49.5M | Sell |
882,375
-220,346
| -20% | -$12.4M | 0.01% | 704 |
|
|
2023
Q1 | $49.9M | Sell |
1,102,721
-20,127
| -2% | -$910K | 0.01% | 683 |
|
|
2022
Q4 | $45.6M | Sell |
1,122,848
-64,614
| -5% | -$2.63M | 0.01% | 688 |
|
|
2022
Q3 | $77.6M | Sell |
1,187,462
-1,827,089
| -61% | -$119M | 0.01% | 536 |
|
|
2022
Q2 | $183M | Buy |
3,014,551
+1,848,437
| +159% | +$112M | 0.02% | 499 |
|
|
2022
Q1 | $73.2M | Buy |
1,166,114
+75,301
| +7% | +$4.73M | 0.01% | 833 |
|
|
2021
Q4 | $82.7M | Sell |
1,090,813
-93,916
| -8% | -$7.12M | 0.01% | 827 |
|
|
2021
Q3 | $133M | Sell |
1,184,729
-4,544
| -0.4% | -$509K | 0.01% | 677 |
|
|
2021
Q2 | $193M | Sell |
1,189,273
-109,056
| -8% | -$17.7M | 0.02% | 574 |
|
|
2021
Q1 | $158M | Sell |
1,298,329
-476,107
| -27% | -$58M | 0.02% | 625 |
|
|
2020
Q4 | $272M | Buy |
1,774,436
+143,504
| +9% | +$22M | 0.03% | 444 |
|
|
2020
Q3 | $136M | Buy |
1,630,932
+255,605
| +19% | +$21.4M | 0.02% | 579 |
|
|
2020
Q2 | $101M | Buy |
1,375,327
+364,124
| +36% | +$26.8M | 0.01% | 637 |
|
|
2020
Q1 | $42.9M | Sell |
1,011,203
-98,969
| -9% | -$4.2M | 0.01% | 830 |
|
|
2019
Q4 | $67.6M | Buy |
1,110,172
+411,929
| +59% | +$25.1M | 0.01% | 794 |
|
|
2019
Q3 | $28.6M | Sell |
698,243
-40,626
| -5% | -$1.67M | ﹤0.01% | 1040 |
|
|
2019
Q2 | $34.8M | Buy |
738,869
+121,176
| +20% | +$5.71M | ﹤0.01% | 1000 |
|
|
2019
Q1 | $22.1M | Buy |
617,693
+1,845
| +0.3% | +$65.9K | ﹤0.01% | 1151 |
|
|
2018
Q4 | $17.6M | Buy |
615,848
+413,212
| +204% | +$11.8M | ﹤0.01% | 1189 |
|
|
2018
Q3 | $8.99M | Buy |
202,636
+3,061
| +2% | +$136K | ﹤0.01% | 1394 |
|
|
2018
Q2 | $11.7M | Buy |
+199,575
| New | +$11.7M | ﹤0.01% | 1319 |
|
|
2017
Q4 | – | Sell |
-151,510
| Closed | -$2.71M | – | 2557 |
|
|
2017
Q3 | $2.71M | Buy |
+151,510
| New | +$2.71M | ﹤0.01% | 1500 |
|